New MACPAC Data on the Highly Effective Medicaid Drug Rebate Program

As I have previously explained, under the highly effective Medicaid Drug Rebate Program, drug manufacturers must provide substantial rebates to the federal government and states as a condition of having their drugs covered by Medicaid.  The rebates apply to both fee-for-service and to managed care.  A groundbreaking 2021 Congressional Budget Office study found that compared […]

Unwinding Wednesday #9: CMS Should Add the Unwinding Supplemental Data to the Medicaid Performance Indicators

In last week’s Unwinding Wednesday blog, my colleague Allie Gardner noted that CMS is requiring states to provide supplemental data for monitoring the unwinding of the Medicaid continuous coverage protection. These data are in addition to the performance indicator data that states have been required to submit monthly since 2013. But … the supplemental data […]